雅虎香港 搜尋

搜尋結果

1. www.drugs.com › international › merislonMerislon (International database) - Drugs.com

   www.drugs.com › international › merislon

   • 網頁紀錄

   Betahistine mesilate (a derivative of Betahistine) is reported as an ingredient of Merislon in the following countries: China. Costa Rica. Dominican Republic. El Salvador. Guatemala. Hong Kong. Indonesia. Japan.

2. www.finanznachrichten.de › nachrichten-2024-03 › 61819182Eisai to Divest Rights for Merislon and Myonal in Japan to K ...

   www.finanznachrichten.de › nachrichten-2024-03 › 61819182

   • 網頁紀錄

   2024年3月29日 · TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon ...

3. www.jcnnewswire.com › pressrelease › 78998Eisai to Divest Rights for Muscle Relaxant Myonal, Vertigo, ...

   www.jcnnewswire.com › pressrelease › 78998

   • 網頁紀錄

   2022年11月7日 · Eisai will retain its manufacturing rights to and continue to distribute the products in countries such as Japan, China and South Korea. DKSH is a leading provider of "Market Expansion Services" that comprehensively supports companies' business growth and entry into new markets, especially in Asia, and is already responsible for supplying Eisai's products in some parts of Asia.

4. www.farmasi-id.com › merislonMerislon | Kandungan, Indikasi, Efek Samping, Dosis, Obat ...

   www.farmasi-id.com › merislon

   • 網頁紀錄

   2024年4月6日 · Perusahaan induknya, Eisai Co. Ltd adalah perusahaan farmasi besar yang berkedudukan di Tokyo, Jepang. Perusahaan ini didirikan pada 1941 dan memiliki sekira 10 ribu karyawan. Akuisisi MGI Pharma oleh Eisai Co. Ltd pada tahun 2007 membuat perusahaan cukup kuat posisinya sebagai produsen obat-obatan onkologi yang menghasilkan produk seperti Dacogen, Aloxi, Hexalen, dan lain-lain.

5. quest3plus.bpfk.gov.my › front-end › attachmentMERISLON ®TABLETS Consumer Medication Information ...

   quest3plus.bpfk.gov.my › front-end › attachment

   Eisai Co., Ltd. Kawashima Plant 1, Kawashimatakehaya-machi, Kakamigahara-shi, Gifu-ken, Japan Product Registration Holder DKSH Malaysia Sdn Bhd B-11-01, The Ascent, Paradigm No.1, Jalan SS7/26A, Kelana Jaya, 47301 Petaling Jaya, Selangor. Author ...

6. www.tradingview.com › news › reutersEisai to Divest Rights for Merislon and Myonal in Japan to K ...

   www.tradingview.com › news › reuters

   • 網頁紀錄

   2024年3月29日 · TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon (generic name: betahistine mesilate) and muscle relaxant Myonal (generic name: eperisone hydrochloride) in Jap…

7. www.vbdata.cn › intelDetail › 140176卫材将把日本市场Merislon®和Myonal®销售权转让给Kaken- ... 簡

   www.vbdata.cn › intelDetail › 140176

   • 網頁紀錄

   2024年3月29日 · Merislon and Myonal have been widely used by patients in Japan for a long time since their launch in 1969 and 1983, respectively. Eisai has determined that divesting rights for these products to Kaken, which has strengths in the products’ disease areas, is the most optimal choice to ensure them to continue contributing to a greater number of patients.